These insights implied the possibility that the NRF3-RAB5-macropinocytosis axis paradoxically interferes with obesity-induced cancer development through attenuation of obesity-induced inflammation and resistance to therapy targeting cancer anabolism (Figure 4). This evidence concerns the gene NFE2L3 and cancer.